BMO Capital Upgrades Intellia Therapeutics (NTLA) to Outperform, 'Risk/Reward Is Now Skewed to the Upside'

March 13, 2023 4:05 PM

(Updated - March 13, 2023 4:06 PM EDT)

BMO Capital analyst Kostas Biliouris upgraded Intellia Therapeutics (NASDAQ: NTLA) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found